Back

Latest Forum Topics / Biosensors

Post Reply

Is Biosensors a good buy? Post Reply Rate topic
infancybird Senior	22-Apr-2013 15:44        infancybird About Contact  Quote this Post!
x 0   x 0  Alert Admin	surprise you all did not notice that last Friday the company`s SGX website indicated that it had just  started its share buy back. A good sign     Flashstep      ( Date: 22-Apr-2013 14:01) Posted: Any chance for this to rebounce? When is the M&A coming?
Useful To Me  Not Useful To Me
Flashstep Member	22-Apr-2013 14:01        Flashstep About Contact  Quote this Post!
x 0   x 0  Alert Admin	Any chance for this to rebounce? When is the M&A coming?
Useful To Me  Not Useful To Me
halleluyah Elite	20-Apr-2013 00:20        halleluyah About Contact  Quote this Post!
x 0   x 0  Alert Admin	Its making me sick also lor....freeze up a lot in the freezer liao....lol. bishan22      ( Date: 17-Apr-2013 15:00) Posted: Not only this counter sick, many others in STI are also sick too. Testing your patience and guts. Good luck.  yiming2000      ( Date: 17-Apr-2013 14:31) Posted: Looks like everybody is sick of this counter. No posting since Apr 10. I am all alone like a good parent vested with this sick baby now.
Useful To Me  Not Useful To Me
yiming2000 Senior	19-Apr-2013 23:51        yiming2000 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Friend edchai, thanks for info. At 1.215 now, you are in safe territory. I will be watching your success as I track my losses which is now $5,300. I bought 20 lots at 1.48 more than one year ago.                                                                                                                                                      When my losses dwindle to zero, you will be making $1,300. Hope this happen soon.
Useful To Me  Not Useful To Me
rbgmauq Member	19-Apr-2013 21:24        rbgmauq About Contact  Quote this Post! Style: Technical
x 0   x 0  Alert Admin	Biosensors (B20) has been showing support around 1.19 and resistance in the 1.301 price range. RSI(14) is 37.5 and increasing.  http://sgx.stoxline.com/quote.php?s=b20
Useful To Me  Not Useful To Me
edchai Senior	19-Apr-2013 21:17        edchai About Contact  Quote this Post!   Mood:
x 0   x 0  Alert Admin	Oops ... Forgot to mention, looking for its reversal sign as well. Will not buy even @1.185 if downtrend continues. Good luck everyone. edchai      ( Date: 19-Apr-2013 21:11) Posted: Friend yiming ... I collected 5 lots @ 1.205. No target set so far and intend to collect more if it goes down further, like 1.185 or below. Lets see what happen next week.
Useful To Me  Not Useful To Me
edchai Senior	19-Apr-2013 21:11        edchai About Contact  Quote this Post!   Mood:
x 0   x 0  Alert Admin	Friend yiming ... I collected 5 lots @ 1.205. No target set so far and intend to collect more if it goes down further, like 1.185 or below. Lets see what happen next week.
Useful To Me  Not Useful To Me
9hly99 Member	19-Apr-2013 13:41        9hly99 About Contact  Quote this Post!
x 0   x 0  Alert Admin	afraid price may trend lower slowly...around 1.15
Useful To Me  Not Useful To Me
yiming2000 Senior	19-Apr-2013 13:29        yiming2000 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Friend edchai, how many lots did you collect? When is Biosensors first quarter announcement? What is your target price for selling to make profit?
Useful To Me  Not Useful To Me
edchai Senior	19-Apr-2013 09:47        edchai About Contact  Quote this Post!   Mood:
x 0   x 0  Alert Admin	Downtrend continues .....
Useful To Me  Not Useful To Me
edchai Senior	17-Apr-2013 17:26        edchai About Contact  Quote this Post!   Mood:
x 0   x 0  Alert Admin	Wanted to post message yesterday but encountered DB error message. Anyway, it's worth looking at this counter now and I collected some today. Good luck ya
Useful To Me  Not Useful To Me
bishan22 Elite	17-Apr-2013 15:00        bishan22 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Not only this counter sick, many others in STI are also sick too. Testing your patience and guts. Good luck.  yiming2000      ( Date: 17-Apr-2013 14:31) Posted: Looks like everybody is sick of this counter. No posting since Apr 10. I am all alone like a good parent vested with this sick baby now.
Useful To Me  Not Useful To Me
yiming2000 Senior	17-Apr-2013 14:31        yiming2000 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Looks like everybody is sick of this counter. No posting since Apr 10. I am all alone like a good parent vested with this sick baby now.
Useful To Me  Not Useful To Me
junction Senior	10-Apr-2013 17:58        junction About Contact  Quote this Post!
x 0   x 0  Alert Admin	You've heard of Fidelity?  Some investors in Singapore buy their unit trusts.  They manage $billions. raykee      ( Date: 10-Apr-2013 13:12) Posted: wat is FIL? i am kind of sick of their management... what so  secretive.... junction      ( Date: 09-Apr-2013 18:19) Posted: Don think it will reverse to 1.21 cos 1. That price was before announcement of EC mark   for Biofreedom 2. usually run up to end of year report 3. presence of FIL to counter shortists.  The vol has fallen drastically for now cos investors are fed up waiting for management to announce acquisition.  Believe it will pick up nearer reporting time. IMO can collect now.  Best hope is more Funds buy into Biosensors and tie up with big pharma to kick out the current management.
Useful To Me  Not Useful To Me
raykee Senior	10-Apr-2013 13:12        raykee About Contact  Quote this Post!
x 0   x 0  Alert Admin	wat is FIL? i am kind of sick of their management... what so  secretive.... junction      ( Date: 09-Apr-2013 18:19) Posted: Don think it will reverse to 1.21 cos 1. That price was before announcement of EC mark   for Biofreedom 2. usually run up to end of year report 3. presence of FIL to counter shortists.  The vol has fallen drastically for now cos investors are fed up waiting for management to announce acquisition.  Believe it will pick up nearer reporting time. IMO can collect now.  Best hope is more Funds buy into Biosensors and tie up with big pharma to kick out the current management.  edchai      ( Date: 08-Apr-2013 09:52) Posted: downtrend now and it may reverse back to $1.21
Useful To Me  Not Useful To Me
junction Senior	09-Apr-2013 18:19        junction About Contact  Quote this Post!
x 0   x 0  Alert Admin	Don think it will reverse to 1.21 cos 1. That price was before announcement of EC mark   for Biofreedom 2. usually run up to end of year report 3. presence of FIL to counter shortists.  The vol has fallen drastically for now cos investors are fed up waiting for management to announce acquisition.  Believe it will pick up nearer reporting time. IMO can collect now.  Best hope is more Funds buy into Biosensors and tie up with big pharma to kick out the current management.  edchai      ( Date: 08-Apr-2013 09:52) Posted: downtrend now and it may reverse back to $1.21
Useful To Me  Not Useful To Me
edchai Senior	08-Apr-2013 09:52        edchai About Contact  Quote this Post!   Mood:
x 0   x 0  Alert Admin	downtrend now and it may reverse back to $1.21
Useful To Me  Not Useful To Me
bishan22 Elite	08-Apr-2013 09:31        bishan22 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Gostan to 20 days. Good luck.  edchai      ( Date: 28-Mar-2013 20:08) Posted: Watch out on next Monday .... it can be bad and keep fingers crossed. Good luck !
Useful To Me  Not Useful To Me
yiming2000 Senior	01-Apr-2013 13:45        yiming2000 About Contact  Quote this Post!
x 0   x 0  Alert Admin	Friend Starlene, I am hanging in there with maxi-cash and rowsley. Glad to know that you are still vested. I'm right beside you.
Useful To Me  Not Useful To Me
ricourean Member	01-Apr-2013 09:06        ricourean About Contact  Quote this Post!
x 0   x 0  Alert Admin	1-Year Results Show New Biolimus Stent Equal To Everolimus Stent Main Category:  Cardiovascular / Cardiology Also Included In:  Medical Devices / Diagnostics Article Date: 13 Mar 2013 - 0:00 PDT   email to a friend        printer friendly        opinions      Current ratings for: 1-Year Results Show New Biolimus Stent Equal To Everolimus Stent Patient / Public: Healthcare Prof: In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to data from the NEXT trial presented at the American College of Cardiology's 62nd Annual Scientific Session.  Drug-eluting stents are structures placed inside narrowed coronary arteries to restore proper blood flow. A polymer coating on these devices slowly releases a drug designed to prevent restenosis - another blockage at the same site - and prevent a second invasive procedure to clear the artery, called target lesion revascularization. The polymer's drug greatly reduces restenosis and target lesion revascularization rates, but the coating itself retards healing in the stented artery and may trigger an inflammatory response that leads to late adverse effects. The clinical challenge is to retain the pros of the drug and minimize or eliminate the cons of the polymer. With a polymer coating that dissolves six to nine month after implantation, the biolimus-eluting stent (BES) may reduce late restenosis or very late clotting on the device (stent thrombosis).  The NEXT trial assigned 3,235 patients to either BES or an everolimus-eluting stent (EES) in the largest multicenter, randomized open-label study comparing these two devices ever reported. BES was approved in Japan in 2011, while EES is the country's leading coronary drug-eluting device. The two eluted compounds belong to the same class of drugs. The study enrolled all patients scheduled for insertion of a drug-eluting stent at 98 participating centers in Japan, with no exclusion criteria.  "Our results suggest that BES could be the alternative to EES, a current gold standard second-generation drug-eluting stent," said Masahiro Natsuaki, MD, of Kyoto University Graduate School of Medicine's Department of Cardiovascular Medicine. "Because the polymer will completely disappear one year after stent insertion, at least a three-year timeframe will be needed to demonstrate the potential advantage of BES over other available stents."  BES met the goal of non-inferiority to EES in target-lesion revascularization at one year, with target lesion revascularization in 67 BES patients vs. 66 EES patients (4.2 percent for both groups). The cumulative rates of definite stent thrombosis were low and similar at 0.25 percent in the BES group vs. 0.06 percent in the EES group. In a substudy of 528 patients, angiographic imaging confirmed similar rates of restenosis in both study arms, expressed as late lumen loss - a shrinkage of space inside the stented artery at 266 days + 43 days after the procedure: loss of 0.03+0.39mm in BES patients vs. 0.06+0.45mm in EES patients.  The study's other primary outcome is death or  heart attack  at three years after stent insertion, with multiple secondary outcome measures for that three-year timeframe. Interim two-year data also will be analyzed.  Many patients in this study were older (mean age 69.2+ 9.8 years), had  diabetes  (46 percent) or already had a coronary stent (51 percent). Analysis found no differences in outcomes for these subgroups between the two stent types. An earlier study's findings had raised concerns about acute success rate with BES - the ability to deliver all intended stents to the target site and achieve the target artery diameter. In this trial, acute success rates were very high for BES and EES at 99.6 percent in both groups.  Dr. Natsuaki observed that despite the study's all-comer design, the actual study population mostly included patients with stable coronary artery disease the one-year rate of target lesion revascularization was lower than expected, leading to a relatively large margin of non-inferiority and the high incidence of follow-up angiography inflated rates of target lesion revascularization. Nevertheless, "Given the equivalent one-year outcome, long-term clinical data for biodegradable-polymer BES compared with durable-polymer EES will have crucial implications for future development of improved metallic drug-eluting stents," he said.
Useful To Me  Not Useful To Me

                                                         First   < Newer   501-520 of 10899   Older>   Last